GUIDI, ALESSANDRA
 Distribuzione geografica
Continente #
AS - Asia 16
EU - Europa 1
Totale 17
Nazione #
CN - Cina 8
KR - Corea 8
IT - Italia 1
Totale 17
Città #
Seoul 8
Rome 1
Totale 9
Nome #
Use of Perhexiline 2
(+)-(R)- and (-)-(S)-Perhexiline maleate: Enantioselective synthesis and functional studies on Schistosoma mansoni larval and adult stages 2
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors 2
Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by 1H-NMR spectroscopy 1
Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production. 1
Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni 1
Comparative metabolic profiling by H-1-NMR spectroscopy analysis reveals the adaptation of S. mansoni from its host to in vitro culture conditions: a pilot study with ex vivo and GSH-supplemented medium-cultured parasites 1
Investigating the Antiparasitic Potential of the Marine Sesquiterpene Avarone, Its Reduced form Avarol, and the Novel Semisynthetic Thiazinoquinone Analogue Thiazoavarone 1
Thiazinoquinones as New Promising Multistage Schistosomicidal Compounds Impacting Schistosoma mansoni and Egg Viability. 1
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production 1
Application of RNAi to Genomic Drug Target Validation in Schistosomes 1
Whole Organism High-Content Screening by Label-Free, Image-Based Bayesian Classification for Parasitic Diseases 1
Development and Validation of a Luminescence-based, Medium-Throughput Assay for Drug Screening in Schistosoma mansoni. 1
Luminescence-based, low- and medium-throughput assays for drug screening in schistosoma mansoni larval stage 1
Totale 17
Categoria #
all - tutte 240
article - articoli 228
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202417 0 0 0 0 0 0 0 0 1 0 16 0
Totale 17